OncoTargets and Therapy
Volume 10, 2017 - Issue
Open access
40
Views
4
CrossRef citations to date
0
Altmetric
Original Research
Real-world experience of everolimus as second-line treatment in metastatic renal cell cancer after failure of pazopanib
Konstantinos Koutsoukos1 Hellenic Genito-Urinary Cancer Group;2 Oncology Unit, Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, GreeceCorrespondence[email protected]
, Aristotelis Bamias1 Hellenic Genito-Urinary Cancer Group;2 Oncology Unit, Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece
, Kimon Tzannis1 Hellenic Genito-Urinary Cancer Group
, Marta Espinosa Montaño3 Medical Oncology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain
, Vasiliki Bozionelou4 Department of Medical Oncology, University Hospital of Heraklion, Heraklion
, Christos Christodoulou5 2nd Oncology Clinic, Metropolitan Hospital, Piraeus
, Dimitra Stefanou6 1st Department of Medical Oncology, Saint Savvas Anticancer Hospital, Athens
, Haralabos Kalofonos7 Division of Oncology, Department of Medicine, University Hospital, University of Patras Medical School, Patras
, Ignacio Duran3 Medical Oncology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain
& Konstantinos Papazisis1 Hellenic Genito-Urinary Cancer Group;8 Euromedica General Clinic, Thessaloniki, Greece
show all
Pages 4885-4893
|
Published online: 06 Oct 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.